Horsepox synthesis: A case of the unilateralist’s curse? – Bulletin of the Atomic Scientists
Brinkwire |
Horsepox synthesis: A case of the unilateralist’s curse?
Bulletin of the Atomic Scientists The possibility that synthetic biology could be used to produce dangerous pathogens (including smallpox) has been expressly discussed for more than a decade. In 2014, the World Health Assembly commissioned a report on the public health implications of … Did Pox Virus Research Put Potential Profits Ahead of Public Safety?Brinkwire (press release) |
GeekWire |
Former VP Joe Biden comes out swinging for science and his cancer moonshot
GeekWire “We’re now firmly in the realm of synthetic biology,” said Rafael Ponce, senior director of preclinical science for Juno Therapeutics. Juno Therapeutics, which was spun out from a consortium of cancer centers in 2013, has been through a series of sharp … |
Nasdaq |
AstraZeneca’s immunotherapy drug wins key lung cancer approval …
Nasdaq LONDON, Feb 17 (Reuters) – AstraZeneca’s immunotherapy drug Imfinzi has won crucial approval from U.S. regulators for use in lung cancer, opening up a multibillion-dollar market for a medicine that has so far lagged behind competitors. The U.S. Food … Immunotherapy Drug Wins Key Lung Cancer OK | Newsmax.comNewsmax UPDATE 2-AstraZeneca’s immunotherapy drug wins key lung cancer approvalLondon South East (blog) AstraZeneca’s cancer therapy Imfinzi gets FDA nodMarketWatch Chicago Evening Post –The Times all 12 news articles » |
Nasdaq |
AstraZeneca’s immunotherapy drug wins key lung cancer approval …
Nasdaq LONDON, Feb 17 (Reuters) – AstraZeneca’s immunotherapy drug Imfinzi has won crucial approval from U.S. regulators for use in lung cancer, opening up a multibillion-dollar market for a medicine that has so far lagged behind competitors. The U.S. Food … Immunotherapy Drug Wins Key Lung Cancer OK | Newsmax.comNewsmax UPDATE 2-AstraZeneca’s immunotherapy drug wins key lung cancer approvalLondon South East (blog) AstraZeneca’s cancer therapy Imfinzi gets FDA nodMarketWatch Chicago Evening Post –The Times all 12 news articles » |
Newsmax |
Immunotherapy Drug Wins Key Lung Cancer OK
Newsmax AstraZeneca’s immunotherapy drug Imfinzi has won crucial approval from U.S. regulators for use in lung cancer, opening up a multibillion-dollar market for a medicine that has so far lagged behind competitors. The U.S. Food and Drug Administration said … |